CDER Recruitment Wins Begin Outnumbering Losses
US FDA's drug center has been hiring more employees than it has lost over the last few months and hopes the Office of New Drugs reorganization will help retention.
You may also be interested in...
US FDA plans to open a manufacturing research lab near its White Oak headquarters in 2021 to facilitate evaluation of novel manufacturing technology.
A departure date has yet to be determined for the associate director of therapeutic biologics, who helped negotiate and implement the biosimilar user fee program.
Bolus of applications could be filed once government reopens, but employee morale and recruitment efforts could suffer drop-off.